China Approves First Gene Therapy for Hemophilia B 
China’s NMPA approves BBM-H901, a breakthrough gene therapy for hemophilia B, offering new hope for patients. 
RareDiseases
China Approves First Gene Therapy for Hemophilia B
China Cuts Rare Disease Diagnosis Time from Years to Weeks 
China slashes rare disease diagnosis time from years to weeks, cuts costs by 90%, and boosts public awareness. 
#Healthcare
China’s Breakthroughs Slash Rare Disease Diagnosis Time and Costs
China is revolutionizing rare disease diagnosis and treatment, cutting diagnosis time from 4 years to under 4 weeks and reducing costs by 90%. 
China Boosts Healthcare Access with Expanded Rare Disease Coverage 
China adds 13 rare-disease drugs to medical insurance, offering hope to patients and advancing treatment networks. A leap for healthcare equity!
Global Rare Disease Summit Kicks Off in Shanghai
Shanghai hosts global experts discussing rare disease research breakthroughs and cross-border collaboration. Challenges remain, but hope is universal. 